COVID-19 Variant Immunologic Landscape Trial (COVAIL Trial)
Clinical trial NCT05289037 · COMPLETED
Trial details
- NCT number
- NCT05289037
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-30
- Primary completion
- 2023-11-22
- Enrollment
- 1270
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.